76 research outputs found

    The battle for biomass: A systematic review of food-feed-fuel competition

    Get PDF
    We review 75 studies on the competition for biomass and production resources such as land, water, labour and capital across food, feed and fuel production. We identified seven factors that are key to the availability and effective use of biomass and production resources. These ranged from ones related to production, such as crop yields to ones related to policy. Many of these factors resulted in trade-offs across different uses of biomass. Studies had different perspectives (e.g. economic, biophysical) on setting priorities for biomass and suggested different solutions to address competition (e.g. marginal lands). To connect these perspectives we suggest a framework that prioritises biomass and production resources for the use of human food before its use as feed or bioenergy.<br/

    Milk production and lamb growth in Ojinegra sheep breed

    Get PDF
    El presente trabajo pretende caracterizar la capacidad productiva de las ovejas de la raza Ojinegra a dos niveles de condición corporal (CC; BAJA, ≤ 2.50 vs. ALTA, > 2.50) y evaluar el crecimiento de sus corderos para la producción de corderos del tipo lechal (10-12 kg de peso vivo a 45 días de edad máxima). Para el ensayo se utilizaron 58 ovejas Ojinegras de Teruel con parto en invierno. La ración provista fue de 1 kg de pienso al día y paja de cereal a voluntad. Se registró el peso vivo peso (PV) de ovejas y corderos semanalmente durante las seis semanas de lactación, y la CC de las ovejas en el parto, a mitad de lactación (3ª semana) y al destete (6ª semana). De estas ovejas se eligió al azar un grupo de 22 ovejas para llevar a cabo el estudio de la producción de leche y concentraciones de metabolitos en sangre relacionados con el balance energético (ácidos grasos no esterificados, AGNE, y β-hidroxibutirato, BHB). Los resultados mostraron que el PV de la oveja Ojinegra (49,0 ± 1,5 kg) se vio afectado por la semana de lactación (P 0,05). Los contenidos de AGNE y BHB en sangre durante la lactación no se vieron afectados por la CC al parto (p > 0,05), mostrando valores medios de AGNE y BHB de 0,30 ± 0,06 y 0,54 ± 0,02 mmol/l, respectivamente. Sin embargo, los AGNE sí decrecieron significativamente a medida que avanzaba la lactación (P 0,05), obteniéndose una producción media de leche de 813 g/día (producción estándar de 702 ml/día). La ganancia media diaria (GMD) de los corderos durante la lactación fue independiente de la CC de la oveja al parto (148 vs. 154 ± 9 g/día, en ALTA vs. BAJA, P > 0,05). El peso medio de los corderos en el momento del destete fue de 9,6 ± 0,3 kg. De este trabajo se puede concluir que la producción de leche de las ovejas de raza Ojinegra de Teruel es moderada, permitiendo un crecimiento limitado de los corderos que puede condicionar el cumplimiento de la edad máxima para alcanzar el peso de la categoría lechal (45 días hasta 10-12 kg). Estos resultados deberían ser contrastados con futuros estudios que evalúen la capacidad lechera y maternal de dicha oveja con distintos sistemas de manejo y alimentación.The aim of this study was to characterize the productive potential of the Ojinegra sheep breed at two levels of body condition score (BAJA, ≤ 2.50 vs. ALTA, > 2.50), so that to prospect the production of suckling lambs (10-12 kg live weight at a threshold of 45 days old). Fifty-eight winter-lambing Ojinegra ewes were used. Ewes were stalled indoors and fed 1 kg of concentrate per day and cereal straw ad libitum. Live weight (PV) of ewes and lambs were registered weekly during lactation (6 weeks). Body condition score (CC) of ewes was measured at lambing and at weeks 3 and 6 of lactation. Twenty-two ewes were randomly selected to evaluate milk production and blood metabolites related with energy balance (nonesterified fatty acids, AGNE, and β-hydroxybutyrate, BHB). Ewes’ PV after lambing was affected by the week of lactation (P 0.05). Blood AGNE and BHB contents were not affected by CC at lambing (P > 0.05), with mean values of 0.30 ± 0.06 and 0.54 ± 0.02 mmol/l for AGNE and BHB respectively. However, AGNE concentration decreased during lactation (P < 0.001). Week of lactation and CC at lambing had no effect on milk production (P > 0.05); with mean milk production of 813 g/day (mean standardized production 702 ml/day). The average daily gain (ADG) of lambs was not affected by ewes’ CC at lambing (148 vs. 154 ± 9 g/day, for ALTA vs. BAJA, respectively; P > 0.05). The average PV of lambs at weaning was 9.6 ± 0.3 kg. In conclusion, milk production of Ojinegra sheep breed is moderate and it might condition the attainment of target 10-12 kg live-weight for suckling lamb category at a maximum age of 45 days old. These results should be confirmed in future studies, assessing the maternal capacity of Ojinegra ewe under diverse management and feeding systems

    Socio-Cultural and Economic Valuation of Ecosystem Services Provided by Mediterranean Mountain Agroecosystems

    Get PDF
    The aim of this work was to elucidate the socio-cultural and economic value of a number of ecosystem services delivered by mountain agroecosystems (mostly grazing systems) in Euro-Mediterranean regions. We combined deliberative (focus groups) and survey-based stated-preference methods (choice modelling) to, first, identify the perceptions of farmers and other citizens on the most important ecosystem services and, second, to value these in economic terms according to the willingness to pay of the local (residents of the study area) and general (region where the study area is located) populations. Cultural services (particularly the aesthetic and recreational values of the landscape), supporting services (biodiversity maintenance) and some regulating services (particularly fire risk prevention) were clearly recognized by both farmers and citizens, with different degrees of importance according to their particular interests and objectives. The prevention of forest fires

    Leakage of nitrous oxide emissions within the Spanish agro-food system in 1961-2009

    Full text link
    Abstract In this paper we examine the trends of nitrous oxide (N2O) emissions of the Spanish agricultural sector related to national production and consumption in the 1961?2009 period.The comparison between production- and consumption-based emissions at the national level provides a complete overview of the actual impact resulting from the dietary choices of a given country and allows the evaluation of potential emission leakages. On average, 1.5 % of the new reactive nitrogen that enters Spain every year is emitted as N2O. Production- and consumption-based emissions have both significantly increased in the period studied and nowadays consumption-based emissions are 45 % higher than production-based emissions. A large proportion of the net N2O emissions associated with imported agricultural godos comes from countries that are not committers for the United Nations Framework Convention on Climate Change Kyoto Protocol Annex I. An increase in feed consumption is the main driver of the changes observed, leading to a arkable emission leakage in the Spanish agricultural sector. The complementary approach used here is essential to achieve an effective mitigation of Spanish greenhouse gas emissions

    The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Get PDF
    Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase&nbsp;1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation&nbsp;disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age&nbsp; 6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score&nbsp; 652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc&nbsp;= 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N&nbsp;= 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in&nbsp;Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in&nbsp;Asia&nbsp;and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701
    corecore